A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants
Clinical trial NCT05292131 · COMPLETED
Trial details
- NCT number
- NCT05292131
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-17
- Primary completion
- 2023-01-09
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.